DE69522808T2 - Verfahren zur herstellung von 2- (1-azabicyclo (2.2.2) oct-3-y)) -2,4,5,6-tetrahydro-1 h-benz (de) isochinolin-1-on und zwischenprodukte - Google Patents

Verfahren zur herstellung von 2- (1-azabicyclo (2.2.2) oct-3-y)) -2,4,5,6-tetrahydro-1 h-benz (de) isochinolin-1-on und zwischenprodukte

Info

Publication number
DE69522808T2
DE69522808T2 DE69522808T DE69522808T DE69522808T2 DE 69522808 T2 DE69522808 T2 DE 69522808T2 DE 69522808 T DE69522808 T DE 69522808T DE 69522808 T DE69522808 T DE 69522808T DE 69522808 T2 DE69522808 T2 DE 69522808T2
Authority
DE
Germany
Prior art keywords
benz
azabicyclo
tetrahydro
oct
isochinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69522808T
Other languages
English (en)
Other versions
DE69522808D1 (de
Inventor
Alois Dvorak
Andrew Kowalczyk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23040964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69522808(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE69522808D1 publication Critical patent/DE69522808D1/de
Application granted granted Critical
Publication of DE69522808T2 publication Critical patent/DE69522808T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69522808T 1994-07-08 1995-07-01 Verfahren zur herstellung von 2- (1-azabicyclo (2.2.2) oct-3-y)) -2,4,5,6-tetrahydro-1 h-benz (de) isochinolin-1-on und zwischenprodukte Expired - Lifetime DE69522808T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/272,715 US5567818A (en) 1994-07-08 1994-07-08 Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein
PCT/EP1995/002556 WO1996001824A1 (en) 1994-07-08 1995-07-01 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product

Publications (2)

Publication Number Publication Date
DE69522808D1 DE69522808D1 (de) 2001-10-25
DE69522808T2 true DE69522808T2 (de) 2002-04-04

Family

ID=23040964

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69522808T Expired - Lifetime DE69522808T2 (de) 1994-07-08 1995-07-01 Verfahren zur herstellung von 2- (1-azabicyclo (2.2.2) oct-3-y)) -2,4,5,6-tetrahydro-1 h-benz (de) isochinolin-1-on und zwischenprodukte

Country Status (16)

Country Link
US (1) US5567818A (de)
EP (1) EP0770077B1 (de)
JP (1) JP2898758B2 (de)
CN (1) CN1048727C (de)
AT (1) ATE205845T1 (de)
AU (1) AU2979995A (de)
BR (1) BR9508249A (de)
CL (2) CL2004001244A1 (de)
CY (1) CY2342B1 (de)
DE (1) DE69522808T2 (de)
DK (1) DK0770077T3 (de)
ES (1) ES2162929T3 (de)
FI (1) FI120198B (de)
MX (1) MX9700157A (de)
PT (1) PT770077E (de)
WO (1) WO1996001824A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001227739B2 (en) 2000-04-20 2005-09-29 Masonite Corporation Reverse molded panel
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
US8614225B2 (en) * 2006-08-30 2013-12-24 Dr. Reddy's Laboratories Limited Process for the purification of palonosetron or its salt
US20100016593A1 (en) * 2006-10-23 2010-01-21 Pierluigi Rossetto Crystalline forms of palonosetron hydrochloride
WO2008073757A1 (en) * 2006-12-07 2008-06-19 Helsinn Healthcare Sa Crystalline and amorphous forms of palonosetron hydrochloride
WO2008146283A2 (en) * 2007-05-29 2008-12-04 Chemagis Ltd. Novel palonosetron salts and processes for preparation and purification thereof
WO2009010987A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved process for the preparation of pure palonosetron hydrochloride
AR069625A1 (es) * 2007-12-13 2010-02-03 Glenmark Generics Ltd Base libre de palonosetron y procedimiento para su preparacion
WO2009087643A1 (en) * 2008-01-11 2009-07-16 Natco Pharma Limited Novel crystalline forms of palonosetron hydrochloride
WO2009136405A1 (en) * 2008-05-05 2009-11-12 Natco Pharma Limited High purity palonosetron base and its solid state characteristics
WO2010056656A2 (en) * 2008-11-11 2010-05-20 Dr. Reddy's Laboratories Ltd. Preparation of crystalline palonosetron hydrochloride
CN101851233B (zh) * 2009-04-03 2013-03-06 四川滇虹医药开发有限公司 盐酸帕洛诺司琼和其前体化合物及制备
US20120267533A1 (en) 2009-06-30 2012-10-25 Ranbaxy Laboratories Limited Processes for the preparation of form i and form ii of palonosetron hydrochloride
WO2011013095A1 (en) 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Processes for the preparation of palonosetron
JP2014070036A (ja) * 2012-09-28 2014-04-21 Mitsubishi Gas Chemical Co Inc １，８−テトラリンジカルボン酸無水物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007191A (en) * 1975-10-14 1977-02-08 E. R. Squibb & Sons, Inc. 2-(Piperidinyl or tetrahydropyridinyl)-alkyl)-2,3-dihydro-3-hydroxy-1H-benz(DE)isoquinolin-1-ones
JPH0662607B2 (ja) * 1989-11-28 1994-08-17 シンテックス（ユー・エス・エイ） インコーポレイテッド 新規三環式化合物
US5202318A (en) * 1990-05-14 1993-04-13 Syntex (U.S.A.) Inc. Tricyclic compounds acting at serotonin receptor subtypes

Also Published As

Publication number Publication date
CN1152313A (zh) 1997-06-18
US5567818A (en) 1996-10-22
CL2004001244A1 (es) 2005-04-15
CY2342B1 (en) 2004-02-06
JP2898758B2 (ja) 1999-06-02
BR9508249A (pt) 1998-01-06
CL2007001958A1 (es) 2008-02-22
WO1996001824A1 (en) 1996-01-25
FI970068A (fi) 1997-01-07
DE69522808D1 (de) 2001-10-25
EP0770077B1 (de) 2001-09-19
DK0770077T3 (da) 2002-01-14
JPH09508645A (ja) 1997-09-02
AU2979995A (en) 1996-02-09
PT770077E (pt) 2002-02-28
MX9700157A (es) 1997-04-30
FI970068A0 (fi) 1997-01-07
FI120198B (fi) 2009-07-31
ES2162929T3 (es) 2002-01-16
ATE205845T1 (de) 2001-10-15
CN1048727C (zh) 2000-01-26
EP0770077A1 (de) 1997-05-02

Similar Documents

Publication Publication Date Title
ATE205845T1 (de) Verfahren zur herstellung von 2- (1-azabicyclo (2.2.2) oct-3-y)) -2,4,5,6-tetrahydro-1 h-benz (de) isochinolin-1-on und zwischenprodukte
DE3581512D1 (de) Verfahren zur herstellung von pyrrolo-(3,4-c)-pyrrolen und neue pyrrolo-(3,4-c)-pyrrole.
DE69529768D1 (de) Verfahren und herstellung zur hydroverwirrung von vliesstoffen
DE69621491T2 (de) Verfahren zur Herstellung von Epsilon-Caprolactam
DE69706863D1 (de) Verfahren zur herstellung von 1,4-butandiol, gamma-butyrolacton und tetrahydrofuran
DE69424024T2 (de) Verfahren zur Herstellung von Laktamen
DE69311817D1 (de) Verfahren zur Herstellung von Kohle-Kohle-Verbund-Vorformen und Kohle-Kohle-Verbund
DE69020172D1 (de) Verfahren zur Herstellung von epsilon-Caprolactam.
DE19581874T1 (de) Verfahren zur Herstellung von Verbundpolstern
DE3783199D1 (de) Verfahren zur herstellung von 4,4' diaminodiphenylmethan und derivaten davon.
ATA41091A (de) Verfahren zur herstellung von beta-(d)-2',3'-didesoxyinosin
DE69106370T2 (de) Verfahren zur herstellung von werkzeugen und matrizen.
DE59506643D1 (de) Verfahren zur herstellung von keramischen verbundkörpern
DE69817797D1 (de) Verfahren zur herstellung von flügelförmigen werkstücken und mit diesem verfahren hergestellte werkstücke
DE69707533D1 (de) Verfahren zur Herstellung von 3-Formyl-tetrahydrofuran
DE69313297T2 (de) Benzofuranone, benzodifurantrione und verfahren zur herstellung von benzodifurandionen
DE69719042D1 (de) Verfahren zur herstellung von epsilon-caprolactam
DE59510636D1 (de) Verfahren zur herstellung von 8-alpha,12-oxido-13,14,15,16-tetranorlabdan
DE69535977D1 (de) Verfahren zur Herstellung von 2-methylspiro(1,3-oxathiolan-5,3')chinuclidin
DE69016188T2 (de) Verfahren zur Herstellung von keramischen Verbundkörpern und so hergestellte Körper.
DE69002134D1 (de) Verfahren zur herstellung von 1,1-dichlor-1-fluoroethan und 1-chlor-1-1-difluorethan.
DE3585388D1 (de) Verfahren zur herstellung von 1,3 cyclohexandionderivaten und zwischenprodukte dazu.
DE69804951D1 (de) Verfahren zur herstellung von (1s,4r)-1-azabicyclo[2.2.1]heptan-3-on und (1r,4s)-1-azabicyclo[2.2.1]heptan-3-on
AT388318B (de) Verfahren und schmiedemaschine zur herstellung von verbundkoerpern
DE69431706T2 (de) Verfahren zur Herstellung von 5-Amino-dihydropyrrol, Zwischenprodukt davon und Verfahren zur Herstellung des Zwischenprodukts

Legal Events

Date Code Title Description
8364 No opposition during term of opposition